Abstract Obsessive compulsive disorder (OCD) has a complex etiology that encompasses both genetic and environmental factors. However, to date, despite the identiWcation of several promising candidate genes and linkage regions, the genetic causes of OCD are largely unknown. The objective of this study was to conduct linkage studies of childhood-onset OCD, which is thought to have the strongest genetic etiology, in several OCD-aVected families from the genetically isolated population of the Central Valley of Costa Rica (CVCR). The authors used parametric and non-parametric approaches to conduct genome-wide linkage analyses using 5,786 single nucleotide repeat polymorphisms (SNPs) in three CVCR families with multiple childhood-onset OCD-aVected individuals. We identiWed areas of suggestive linkage (LOD score ¸2) on chromosomes 1p21, 15q14, 16q24, and 17p12. The strongest evidence for linkage was on chromosome 15q14 (LOD = 3.13), identiWed using parametric linkage analysis with a recessive model, and overlapping a region identiWed in a prior linkage study using a Caucasian population. Each CVCR family had a haplotype that co-segregated with OCD across a »7 Mbp interval within this region, which contains 18 identiWed brain expressed genes, several of which are potentially relevant to OCD. Exonic sequencing of the strongest candidate gene in this region, the ryanodine receptor 3 (RYR3), identiWed several genetic variants of potential interest, although none co-segregated with OCD in all three families. These Wndings provide evidence that chromosome 15q14 is linked to OCD in families from the CVCR, and supports previous Wndings to suggest that this region may contain one or more OCD susceptibility loci.
Introduction
Although multiple etiologic factors are important in the development of obsessive-compulsive disorder (OCD), there is strong evidence for a genetic contribution, particularly when symptoms begin in childhood (Pauls 2008) . Several promising candidate genes have been identiWed for OCD, including SLC1A1 (Dickel et al. 2006; Arnold et al. 2006) . However, these genes, if conWrmed, will only account for a small proportion of the genetic variance of this complex disorder. Large-scale genome-wide association studies (GWAS) are currently underway for OCD; however, such studies will most likely account for only a proportion of the total disease variation (Yang et al. 2011; Manolio et al. 2009 ). For example, the estimated proportion of the variance explained by all currently reported genetic loci identiWed by GWAS for height, a complex trait with a heritability of 80-90%, is approximately 10%; this number increases to 45% with recently developed genomic partitioning approaches, but still does not approach 100%. Similar results are seen with categorical traits such as type 2 diabetes and Crohn's disease, where published susceptibility loci account for 6 and 20% of the total variance, respectively (Manolio et al. 2009 ). Linkage studies represent a complementary approach to candidate gene studies and GWAS where GWAS are useful for the identiWcation of common variants with relatively small eVect sizes, linkage studies are useful for the identiWcation of rare variants with larger eVect sizes that are increasingly believed to underlie a substantial proportion of the risk for complex disorders (Cirulli and Goldstein 2010) .
To date, three primary linkage studies for OCD have been published, along with two secondary analyses and one targeted replication; these studies have identiWed several genomic candidate regions for OCD (Supplemental Table 1 ) (Wang et al. 2009; Samuels et al. 2007; Hanna et al. 2007; Shugart et al. 2006; Hanna et al. 2002; Willour et al. 2004) . None of the studies using OCD as the primary phenotype identiWed regions meeting genome-wide signiWcance criteria for linkage, although two re-analyses of a large OCD aVected-sib pair sample using alternate phenotypes or sample selection did identify signiWcant linkage regions (Samuels et al. 2007; Wang et al. 2009 ). The Wrst re-analysis included only families with two or more members aVected with compulsive hoarding, and identiWed a region on chromosome 14q with a LOD score of 3.7, and the second focused on families with male probands only, and identiWed a region on chromosome 11p with an initial LOD score of 2.92 and a subsequent LOD score of 5.08 following Wne mapping with additional markers (Samuels et al. 2007; Wang et al. 2009 ).
As linkage and segregation studies suggest, the identiWcation of susceptibility genes in OCD is likely confounded by a complex oligogenetic architecture, as well as genetic and environmental heterogeneity across populations (Cavallini et al. 1999; Geller et al. 2007; Eapen et al. 2006; Hanna et al. 2005; Nestadt et al. 2000) . One approach to reduce genetic and environmental heterogeneity in such complex traits is to conduct studies using multiple aVected families in genetically isolated founder populations (Mathews et al. 2004; Hovatta et al. 1999) . Studies in these populations beneWt from decreased genetic heterogeneity due to decreased migration and, in some cases, increased inbreeding over a deWned period of time (Mathews et al. 2004) . Additional potential advantages include the possibility for decreased environmental heterogeneity due to the isolation of the population, and for decreased phenotypic heterogeneity due to cultural variations in symptom expression, interpretation, or reporting.
We report on the results of linkage and sequencing studies in three multiply aVected OCD pedigrees from the genetically isolated population of the Central Valley of Costa Rica (CVCR), a population with a well-documented history as a genetic isolate, and one in which founder haplotypes for several inherited diseases have been demonstrated (Uhrhammer et al. 1995; Leon et al. 1992 ).
Materials and methods

Families and subjects
As a part of ongoing genetic studies of OCD in Costa Rica, we identiWed three families with two or more OCD-aVected individuals and CVCR ancestry for whom DNA was available from individuals in at least two generations (Fig. 1 ). Families were originally ascertained via probands with DSM-IV OCD whose obsessive-compulsive symptoms began before age 18, who did not have Tourette Syndrome (TS), a pervasive developmental disorder, bipolar disorder, schizophrenia, or a primary psychotic disorder. The study was approved by the Institutional Review Boards of the University of California, San Francisco, the University of California, San Diego, the Johns Hopkins School of Medicine and the Hospital Nacional de Niños in San José, Costa Rica. After complete discussion of the study with the participants, written informed consent or assent was obtained; parental permission was also obtained for participants under age 18.
Clinical assessments were conducted in Spanish by psychiatrists and psychologists specializing in OCD and trained in the research instruments (CAM, HG, and MB). Primary assessment instruments included the Yale Brown Obsessive Compulsive Scale (YBOCS), the Diagnostic Interview for Genetics Studies (DIGS) for adults, and the Kiddie Schedule for AVective Disorders and Schizophrenia (KSADS) for children under 18. Additional clinical assess-ments included the Leyton Obsessional Inventory, childhood version (LOI-CV), the Structured Clinical Interview for DSM-IV Axis II diagnoses (SCID II), and a semi-structured interview that assessed time course and impact of symptoms, presence and severity of related symptoms (including tics), and developmental, school, social, and family history. Diagnoses were assigned using a best estimate consensus approach using all available clinical data by two research clinicians (DC, MG) who were blinded to the presumed clinical diagnosis, family history, or relationship within the pedigree (Leckman et al. 1982; Chavira et al. 2007) . Two OCD diagnoses were assigned: narrow and broad OCD. A diagnosis of narrow OCD was given if the individual met all of the DSM-IV criteria for OCD. A diagnosis of broad OCD encompassed both DSM-IV OCD and subclinical OCD, which was considered present if the individual had Wve or more obsessive-compulsive symptoms that were persistent, took less than an hour, and caused some distress and/or impairment (even if mild), or if the symptoms took an hour or more, but were associated with minimal distress or impairment. The broad deWnition was designed to capture a robust phenotype that is likely to be etiologically related to OCD, but was not severe enough to meet strict DSM-IV criteria for OCD. We required the presence of at least Wve obsessive-compulsive symptoms to ensure that isolated (usually ego-syntonic) symptoms (for example, a cluster of two or three related cleaning behaviors causing little to no distress or impairment), which occur frequently in the population, but may not be etiologically related to OCD, were not included in the phenotype deWnitions, to avoid the introduction of phenocopies. Consistent with this aim, individuals with one to four obsessive-compulsive symptoms were coded as phenotype unknown. The age of onset of obsessive-compulsive symptoms was assessed in all individuals. The average age of onset was 10.9, and all individuals had childhood-onset of symptoms (range 3-18).
Genotyping
DNA extraction was performed from blood or immortalized lymphoblastoid cell lines according to standard procedures. Genotyping was performed on approximately two-thirds of the sample at the Southern California Genotyping Consortium (SCGC) using the Illumina linkage panel IVa; the remaining sample was genotyped at the UCSF Genome Core Facility (UCSF GCF) using the Illumina linkage panel IVb. Only markers that were present in both linkage panels were retained (N = 5,858). Data for each sample were analyzed for quality control and Mendel errors using GenomeStudio Data Analysis software (Illumina). The average call rate for the 5,858 SNPs was 0.99. After initial data cleaning on each sample, data from the two sample sets were merged, and additional data cleaning and quality control procedures were performed. Error checking was completed using Illumina GenomeStudio, Progeny and Pedcheck (Lab; O'Connell and Weeks 1998). Markers that showed Mendelian inconsistency, those that were not in Hardy-Weinberg equilibrium (HWE) (exclusion threshold p < 0.0001), and those with <95% call rates were removed from the marker set, resulting in a Wnal total of 5,786 SNPs (98.8%) retained for analysis. The threshold for exclusion of individual samples was set at genotyping call rates <90%. However, all genotyped individuals passed this threshold and therefore, none were excluded.
Statistical analysis
To maximize the power of this small sample, the primary analysis was a multipoint parametric linkage analysis. We chose to examine a model-based approach (dominant and recessive models) as our primary analysis, in addition to the secondary non-parametric (model-free) analysis, to maximize the power of this small sample, and because examination of the pedigrees suggested that either a dominant or a recessive mode of inheritance was possible (Fig. 1) . Simulation studies have shown that formulating a genetic model that approximates the true inheritance may have more power than nonparametric analyses (Greenberg et al. 1998) . Pedigree relationships were conWrmed prior to analysis using PREST and PLINK. Parametric linkage analyses were conducted using MORGAN version 3.0 and Merlin (Wijsman et al. 2006; Abecasis et al. 2002) . MORGAN uses genetic and phenotypic information from all available family members. Before performing the linkage analysis, the linkage panel was pruned so that only SNPs with a pairwise r 2 · 0.5 were analyzed (N = 2,526), to avoid an increase in false positives that may occur when linkage disequilibrium (LD) between SNPs is not taken into cons. In contrast, MERLIN has the capacity to analyze all SNPs, accounting for LD, but is not able to use all individuals due to the size and complexity of the largest family. For the MERLIN analysis, PedShrink was used to trim the pedigrees as needed, with priority on trimming uninformative individuals (Schaid 2009) . For the dominant model, we assumed a disease allele frequency of 0.01, a penetrance of 0.01 for the wild-type genotype (dd), a penetrance of 0.6 for the heterozygote (Dd) and homozygote genotypes (DD), where D is the disease-causing allele and d is the wild-type allele, resulting in a phenocopy rate of 45%. For the recessive model, we assumed a disease allele frequency of 0.10, a penetrance of 0.01 for the wildtype and heterozygote genotypes, and a penetrance of 0.6 for the homozygote genotype, resulting in a phenocopy rate of 50%. These parameters were chosen to model a relatively rare locus with a large eVect size, as might be expected to occur in families with multiple aVected individuals collected from a genetically isolated population. We used two phenotypes, narrow and broad OCD, as described above. Individuals with subclinical OCD, who were coded as aVected for the broad analyses, were coded as unknown in the narrow analyses. Nonparametric linkage analyses (NPL) were conducted using Simwalk2snp, using the LD-pruned SNP panel (Sobel et al. 2001) . The primary parameters examined were the NPL-pairs statistic, which is a measure of allele sharing among aVected relative pairs (roughly equal to the sum of the conditional kinship coeYcient for all aVected relativepairs), and the NPL-all statistic, which is a measure of whether a few founder alleles are overly represented in the aVected individuals. Critical signiWcance thresholds for suggestive and signiWcant NPL scores were generated for NPLall (3.38 for signiWcant linkage and 2.35 for suggestive linkage) and NPL-pair scores (3.92 for signiWcant linkage and 3.07 for suggestive linkage) from the data using the autoregressive method described by Bacanu (2005) .
Haplotype analysis and candidate gene selection Chromosomal regions that had >5 consecutive SNPs with LOD or NPL scores (either NPL-pairs or NPL-all) ¸2.0 were identiWed as being of interest for further investigation, and were prioritized according to the following criteria: (1) the magnitude of the LOD score; (2) the number of consecutive markers with LOD scores ¸2, (3) identiWcation as a region of interest for OCD in previous linkage analyses, or known to contain candidate genes for OCD, and (4) presence of a haplotype that co-segregated with the OCD phenotype.
Estimated haplotypes were generated for each pedigree using the "haplotype analysis" command in Simwalk2snp. The haplotypes were then visualized using Haplopainter (Thiele and Nurnberg 2005) . As a further check, haplotypes were also constructed by hand (blind to the results generated by Simwalk2snp) for the most signiWcant regions of interest and compared with the results of the haplotype analysis for discrepancies. Haplotypes that were inherited identical by descent and co-segregated with the OCD phenotype were assessed within each family. The families were then assessed to identify haplotypes or portions of the haplotypes that were shared across families. After the genomic region of highest interest was determined, candidate genes within the region were identiWed for further exploration. Initially, all genes and transcripts were identiWed using the UCSC genome browser, assembly GRCh37 (http:// www.genome.ucsc.edu/). Only those genes that were identiWed as brain expressed in the UCSC genome browser were examined further. Candidate genes were then ranked according to (1) whether they had been previously associated with OCD; (2) where in the brain they were expressed, with priority given to those expressed in regions that have been associated with OCD (i.e., striatum, orbitofrontal cortex, thalamus, hippocampus, cingulate); and (3) where they fell under the linkage peak, with priority given to those with the strongest evidence for linkage (Menzies et al. 2008) . The top ranking candidate gene was then sequenced as described below.
Sequencing
Sequencing of the top candidate gene was conducted in selected OCD-aVected individuals from each family. Individuals for sequencing were chosen from within each family so as to maximize the information and minimize the number of total individuals sequenced. In family 2, three individuals who carried the haplotype in the area of interest (1 from each living generation; individuals 1, 13, and 23), and two OCD-aVected individuals who did not carry the haplotype (individuals 7 and 16) were sequenced. In family 1, where phenotypes were known for all family members, all individuals were sequenced, and in family 3, the two OCD-aVected siblings were sequenced, while the parents, who had unknown phenotypes and were therefore not informative, were not. Note that the mother in family 1 endorsed OCS that did not meet the threshold for subclinical OCD; therefore, she was coded as unknown in the genetic analyses. The exons and 150 bp on either side of the exon were sequenced. Sequence data were viewed and analyzed with the Sequencher program (GeneCodes), and sequence variants were identiWed by comparison with the reference human genome. Sequence variants were conWrmed by sequencing the opposite strand using the Sanger sequencing method. All sequence variants that were present in the OCD-aVected individuals, both those carrying the haplotype of interest and those who did not carry the haplotype were investigated further. We examined both non-synonymous and synonymous coding changes within exonic regions, as well as sequence variants within non-coding regions. Predicted function of identiWed variants was assessed using SIFT; if SIFT was unable to identify the variant, F-SNP (http://www.genepi_toolbox.i-med.ac.at/), an integrated functional prediction tool that searches across multiple databases (e.g., Ensembl, RESCUE_ESE, SIFT, etc.), was used to assess predicted function (Ng 2001; Ng and HenikoV 2003; Yuan et al. 2006; Lee and Shatkay 2008) .
Results
Parametric linkage analysis
We carried out parametric linkage analysis on the three families shown in Fig. 1 for the narrow and broad phenotypes under both autosomal dominant and autosomal recessive models. We identiWed 11 chromosomal regions with LOD scores ¸1.5, a threshold commonly used to identify areas of interest in linkage studies, and four with LOD scores ¸2 (Table 1) . Three of these regions met our criteria for further investigation. The Wrst was on chromosome 15q14, with a maximum LOD score of 3.13 under the recessive model using the broad phenotype, the second was on chromosome 1p21, which had a LOD score of 2.16 under recessive model using the narrow phenotype, and the third was on chromosome 16q24, and had a LOD score of 2.15 under the dominant model using the narrow phenotype. The heterogeneity alpha for the region on chromosome 15 was 1.0, suggesting that all three families contributed to the LOD score in this region. The peak individual family LOD scores in this region were 0.7813 (family 1), 1.8758 (family 2), and 0.474 (family 3). Figure 2 shows the LOD scores for chromosomes 1, 15, and 16; LOD scores for the other chromosomes are in Supplemental Figure 1 . The LOD scores for family 2, which contributed the most to the overall LOD score on chromosome 15q14, are shown in Supplemental Figure 2 .
Examination of haplotypes
We examined the haplotypes generated by Simwalk2snp for the chromosome 15q14, chromosome 1p21, and chromosome 16q24 regions, with a primary focus on chromosome 15q. All three families contributed to the LOD score on chromosome 15q, which showed the strongest evidence of linkage, and had been identiWed in a previous linkage study of OCD as a region of interest (Shugart et al. 2006) . In each of the families, we identiWed a conserved haplotype that co-segregates with OCD on 15q, encompassing the region with the highest genome-wide LOD scores. In family 1 (see Fig. 1 for family structures) , all four siblings carried a common haplotype inherited from the OCD-aVected father; the three OCD-aVected siblings also carried a smaller haplotype in this region inherited from the mother, who endorsed some obsessive compulsive symptoms, but did not meet the full best estimate criteria for the broad phenotype and therefore was coded as phenotype unknown. In family 3, the two OCD-aVected siblings carried a shared haplotype inherited from the mother and one inherited from the father; both parents' phenotypes are unknown. In family 2, the largest of the families, 9 of 11 individuals with the narrow phenotype, and one individual who is an obligate carrier and has the broad phenotype (subclinical OCD) shared a haplotype, including the three aVected siblings in the founding generation (Fig. 3) . Two individuals with the narrow phenotype (a mother and son pair) did not carry the shared haplotype. While there was haplotype sharing within each family, we did not identify a haplotype that was shared by all three families.
The region of chromosome 15q as deWned by the conserved haplotype in family 2 covers approximately 15 Mbp and contains 18 brain-expressed genes (Supplemental Table 2 ). In combining the information provided from recombinations that deWned the haplotypes in each of the families, we were able to narrow the region of interest on 15q from 15 Mbp to approximately 7 Mbp (bounded by SNPs rs1520942 and rs1003223).
Although all brain-expressed genes in this region are potentially of interest as candidate genes for OCD, the SNPs with the strongest evidence of linkage in all families (6 consecutive SNPs) were located in the intronic region between exons 1 and 2 of the ryanodine 3 receptor (RYR3). According to the Allen Brain Atlas, RYR3 is broadly expressed in human brain, with high levels of expression in the cingulate gyrus, hippocampus, parahippocampal gyrus, occipital and parietal lobes, temporal lobe, globus pallidus, striatum (including the caudate and putamen), dorsal thalamus, pontine tegmentum, and myelencephalon (Allen Brain Atlas Resources 2009). Functional and structural imaging studies have consistently implicated several of these regions in OCD pathophysiology, particularly the cingulate gyrus, the hippocampus, the striatum, and the thalamus (Takeshima et al. 1996; Rauch et al. 2001; Nakashima et al. 1997; Menzies et al. 2008) . For these reasons, we chose RYR3 as our top candidate for sequencing. RYR3 is a large gene, with 103 exons, and encoding 4,870 amino acids.
Sequencing of RYR3
We identiWed 184 sequence variants in the exons and surrounding intronic regions that diVered between our sample and the reference human genome, 23 (12.5%) of which were novel. The variants identiWed included 9 non-synonymous coding variants, two of which were novel, and 16 synonymous coding variants, two of which were novel. However, none of the identiWed coding variants were uniquely associated with OCD in all families, although six were associated with the major haplotype of interest in one of the three families (highlighted in gray in Supplemental Table 3 ).
We also identiWed 159 intronic variants in the 150 bp regions surrounding the exons; of these, 19 were novel. None of the variants segregated perfectly with the haplotype of interest in all three families, although 48 variants had allele frequencies of <0.5 and were present on the haplotype of interest in at least one of the two larger families (Supplemental Table 3 ). The intronic variants included several that are predicted by programs such as FastSNP and F-SNP to have potential functional eVects (to be involved in splice site regulation, for example) (Supplemental Table 3 ). 
Discussion
Our results provide evidence from linkage and haplotype studies that chromosome 15q14 may harbor one or more susceptibility genes for OCD. This study speciWcally focused on OCD-aVected families from the genetically isolated population of the CVCR, which has the potential advantage of increasing the power to detect linkage even in a relatively small number of families. In fact, even with only three families, the linkage Wnding on chromosome 15 is the strongest that has yet been reported for a primary analysis of OCD, and is further strengthened by the identiWcation of shared haplotypes within each family that co-segregate with the OCD phenotype. The utility of looking for individual or private mutations in relatively small numbers of families from speciWc populations such as the CVCR has Chromosome 15q14-15 has been previously implicated as a region of interest for OCD in a linkage analysis using aVected-sib pair families (Shugart et al. 2006 ). The Shugart et al. study, which used a non-parametric analysis and comparable phenotype deWnitions to those used in this study, identiWed a Kong and Cox LOD score of 1.32 under the broad phenotype on chromosome 15q13-15q35. Chromosome 15q14-15 has also been implicated in studies of compulsive behavior in mice, where linkage to compulsive wheel running was found on mouse chromosomes 2, 6, and 7; the linked region of the mouse chromosome 2 is homologous to the human chromosome 15q region identiWed previously and in our study (Kas et al. 2010 ). In addition, multiple SNPs in the 15q14 region have recently been found to be associated with both OCD and with Tourette Syndrome, a closely related neuropsychiatric disorder, in GWAS (p »10 ¡4 ) (J. Scharf and SE Stewart, personal communication, unpublished data). However, to date, no gene in this area has been extensively examined for evidence of a relationship to OCD.
Although there are multiple potential candidate genes of interest for OCD in this region, we chose to examine RYR3, which is of particular interest as a candidate gene for OCD not only because of the localization of the strongest linkage signal in our study to this gene, but also because of its brain expression patterns and its potential relationship to fear conditioning and synaptic plasticity (Rauch et al. 2001; Nakashima et al. 1997; Matsuo et al. 2009; Balschun et al. 1999) . We were unable to identify any sequence variants that were both associated with OCD in all three families and were predicted to have a clear functional eVect, although we did identify SNPs that were associated with OCD in two of the three families, and were predicted by in silico methods to have a potential functional impact on the RYR3 protein.
The ryanodine receptors are calcium-induced calcium release (CICR) channels primarily located in smooth and cardiac muscle (Takeshima et al. 1996) . RYR3 is expressed in smooth muscle at low levels, but appears to be primarily expressed in brain; as noted previously, it is expressed at high levels in multiple areas implicated in OCD pathology (Rauch et al. 2001; Nakashima et al. 1997) . Calcium inXux via AMPA-type glutamate receptors has been shown to elicit CICR from ryanodine receptors in rat ganglion cells, suggesting a relationship between glutamate, which has been implicated in OCD pathophysiology, and ryanodine (Morton-Jones et al. 2008) . Similarly, RYR3 interacts with BDNF to promote hippocampally mediated spatial memory learning and memory consolidation (Adasme et al. 2011) . Mutant mice lacking RYR3 show impaired spatial learning, impaired hippocampal synaptic plasticity, and impairments in contextual fear conditioning and deWcits in social interactions (Matsuo et al. 2009; Balschun et al. 1999; Kouzu et al. 2000 ). RYR3's eVect on fear conditioning appears to be modulated through its ability to activate Ca 2+ /calmodulin-dependent protein kinase II (CaMKII), which is one of the key synaptic molecules involved in long-term fear memory formation, and is highly expressed in the amygdala and hippocampus (Radwanska et al. 2010) .
Limitations
There are two main limitations to this study that potentially limit the generalizability. The Wrst is that the sample size is relatively small, and although all three of the families studied contribute to the linkage signal on chromosome 15q14, the majority of the signal comes from family 2, the largest and most complex pedigree. The second limitation is that we used multiple analytic approaches and two phenotypic models, increasing the risk of identifying a false positive. Despite the multiple models tested, however, we believe that the linkage results, which are consistent across multiple phenotypic and analytic models, are compelling, and as noted, are congruent with Wndings from previous genetic studies of OCD and OCD-like behaviors. The third limitation is that our sequencing studies did not provide clear and compelling evidence of a causal sequence variant in the exonic regions of the primary candidate gene of interest, RYR3. Given the phenotypic and genetic heterogeneity of OCD, our Wndings do not entirely rule out RYR3 as a candidate gene, as future studies may identify functionally signiWcant variants in the intronic or regulatory regions. Further, as will likely be the case for many complex neuropsychiatric disorders, genetic heterogeneity, the presence of phenocopies, and incomplete penetrance within families may make the identiWcation of speciWc causal variants in a given linkage region diYcult without complete targeted sequencing eVorts followed by functional studies of the identiWed associated variants.
Summary
In summary, our results, in combination with the previously reported OCD linkage studies, recent genome-wide association studies, and mouse studies of the chromosome 15 homologous region, provide multiple lines of evidence to implicate chromosome 15q14 in genetic susceptibility for OCD, and suggest that RYR3, and potentially several other brain-expressed genes under this linkage peak, the nicotinic receptor (CHRNA7) and the muscarinic cholinergic receptor (CHRM5), for example, are worth investigating more fully as potential candidate genes. Follow-up studies are needed to validate and extend these Wndings, including replication of the linkage Wndings in additional families, both from the CVCR and other populations, sequencing of the intronic and surrounding regions of the RYR3 gene, examination of the other brain-expressed genes in this region, and molecular studies aimed at elucidating the functional impact of the identiWed sequence variants.
